Davis A - Search Results

1

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, Ray R, O'Meally D, Scott TA, McMillan NAJ, Morris KV. Idris A, et al. Among authors: davis a. Mol Ther. 2021 Jul 7;29(7):2219-2226. doi: 10.1016/j.ymthe.2021.05.004. Epub 2021 May 14. Mol Ther. 2021. PMID: 33992805 Free PMC article.

2

Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator.

Villamizar O, Waters SA, Scott T, Saayman S, Grepo N, Urak R, Davis A, Jaffe A, Morris KV. Villamizar O, et al. Among authors: davis a. Mol Ther. 2019 Oct 2;27(10):1737-1748. doi: 10.1016/j.ymthe.2019.07.002. Epub 2019 Jul 15. Mol Ther. 2019. PMID: 31383454 Free PMC article.

3

Harnessing Rift Valley fever virus NSs gene for cancer gene therapy.

Davis AM, Scott TA, Morris KV. Davis AM, et al. Cancer Gene Ther. 2022 Oct;29(10):1477-1486. doi: 10.1038/s41417-022-00463-4. Epub 2022 Apr 7. Cancer Gene Ther. 2022. PMID: 35393569 Free PMC article.

4

Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles.

Davis A, Morris KV, Shevchenko G. Davis A, et al. Mol Ther Methods Clin Dev. 2022 Mar 16;25:158-169. doi: 10.1016/j.omtm.2022.03.008. eCollection 2022 Jun 9. Mol Ther Methods Clin Dev. 2022. PMID: 35402634 Free PMC article.

5

Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells.

Urak R, Gittins B, Soemardy C, Grepo N, Goldberg L, Maker M, Shevchenko G, Davis A, Li S, Scott T, Morris KV, Forman SJ, Wang X. Urak R, et al. Among authors: davis a. Cancers (Basel). 2023 May 20;15(10):2848. doi: 10.3390/cancers15102848. Cancers (Basel). 2023. PMID: 37345185 Free PMC article.

6

Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.

Davis AM, Ramirez J, Newcomb LL. Davis AM, et al. Virol J. 2017 Feb 7;14(1):22. doi: 10.1186/s12985-017-0694-8. Virol J. 2017. PMID: 28173821 Free PMC article.

7

microRNA-142 guards against autoimmunity by controlling Treg cell homeostasis and function.

Wang WL, Ouyang C, Graham NM, Zhang Y, Cassady K, Reyes EY, Xiong M, Davis AM, Tang K, Zeng D, Boldin MP. Wang WL, et al. PLoS Biol. 2022 Feb 18;20(2):e3001552. doi: 10.1371/journal.pbio.3001552. eCollection 2022 Feb. PLoS Biol. 2022. PMID: 35180231 Free PMC article.

8

Effect of Age and Unaided Acoustic Hearing on Pediatric Cochlear Implant Users' Ability to Distinguish Yes/No Statements and Questions.

Buss E, Richter ME, Sweeney VN, Davis AG, Dillon MT, Park LR. Buss E, et al. Among authors: davis ag. J Speech Lang Hear Res. 2024 May 15:1-13. doi: 10.1044/2024_JSLHR-23-00631. Online ahead of print. J Speech Lang Hear Res. 2024. PMID: 38748909

9

A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.

Tsui TCO, Torres SC, Bielecki JM, Mitsakakis N, Trudeau ME, Bremner KE, Davis AM, Krahn MD. Tsui TCO, et al. Among authors: davis am. Health Qual Life Outcomes. 2024 May 14;22(1):38. doi: 10.1186/s12955-024-02253-y. Health Qual Life Outcomes. 2024. PMID: 38745165 Free PMC article. Review.

10

Nature-Based Design in Stroke Rehabilitation Environments: A Scoping Review.

Seale B, Davis A, Lawson J, Smith L, Watson J, Henderson-Wilson C. Seale B, et al. Among authors: davis a. HERD. 2024 May 14:19375867241251832. doi: 10.1177/19375867241251832. Online ahead of print. HERD. 2024. PMID: 38742749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,524 results

Search Page